Skip to main content
  • English
  • Français
  • About Us
    • About Us
    • Our Purpose and Identity
    • Integrated Report 2021
    • Governance
      • Governance
      • Board of Directors
      • Executive Committee
    • Where we are
    • Through time
    • All Our Stories
      • All Our Stories
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
  • Your Health
    • Your Health
    • Health and Well-Being
    • Diabetes and Cardiovascular Diseases
    • Specialty Care
      • Specialty Care
      • Rare Diseases
      • Rare Blood Disorders
      • Neurology
      • Immunology
      • Oncology
        • Oncology
        • When Cancer Grows Old
          • When Cancer Grows Old
          • Contributions Initiative
          • Global collaboration
      • Patient Support
    • Vaccines
      • Vaccines
      • The Value of vaccines
      • How immunization works
      • Infection Disease and Vaccine
        • Infection Disease and Vaccine
        • COVID-19
        • Influenza
        • Meningococcal Meningitis
        • Pertussis
        • Poliomyelitis
        • Respiratory Syncytial Virus
        • Discover more
      • Research and Innovation
      • Vaccines Production
      • Vaccines Stories
  • Science & Innovation
    • Science & Innovation
    • Partnering
      • Partnering
      • Let's partner
      • Areas of Interest
        • Areas of Interest
        • China & Emerging Markets
        • Digital
        • General Medicines
        • Immunology
        • Neuroscience
        • Oncology
        • Out-Licensing
        • Rare Diseases
        • Technology Platforms
        • Vaccines
      • Meet the team
    • Research & Development
      • Research & Development
      • Sanofi Pipeline
      • Vaccines
      • Immunology and Inflammation
      • Neurology
      • Oncology
      • Pioneering Technology Platforms
        • Pioneering Technology Platforms
        • Genomic Medicine Technology Platform
        • mRNA Technology: Vaccines and Beyond
        • NANOBODY® Technology Platform
        • SYNTHORIN™ Technology Platform
      • Rare Blood Disorders R&D
      • Rare Diseases
      • Voices from the Lab
    • Clinical Trials & Results
      • Clinical Trials & Results
      • Phases
      • Our disclosure commitments
        • Our disclosure commitments
        • Sanofi Pharma
        • Sanofi Genzyme
        • Sanofi Pasteur
      • Our data sharing commitments
      • Managed Access Programs (MAPs)
      • Investigator Sponsored Studies and Externally Sponsored Collaboration
    • Collaboration & Awards
      • Collaboration & Awards
      • Europe
        • Europe
        • iAwards
        • iDEA-iTECH
      • North America
        • North America
        • iAwards
        • iDEA-iTECH
    • Science Stories
  • Our Responsibility
    • Our Responsibility
    • Access to Quality Healthcare – Sanofi Global Health
    • Environmental sustainability
    • Diversity, Equity and Inclusion
      • Diversity, Equity and Inclusion
      • Making an Impact
      • Board & Employee Groups
      • Gender Balance
        • Gender Balance
        • Women@Sanofi
      • Our Partners
      • Our LGBTQ+ Voice
    • Healthcare for all
      • Healthcare for all
      • Sanofi Humanitarian Aid Programs
      • Contributing to the eradication, elimination and control of some infectious diseases
      • Fighting Against Falsified Medicine
      • Serving the needs of patients with non-communicable diseases
    • Corporate Citizenship
    • Foundation S (Endowment Fund)
    • Ethics & Transparency
      • Ethics & Transparency
      • Code of Ethics
    • Suppliers
    • Document center
      • Document center
      • All factsheets
      • Access to Healthcare and Pricing
      • Country reports and other documents
      • CSR Strategy and Value Creation
      • Environment
      • Duty of Vigilance incl. Supply Chain
      • Ethics & Transparency
      • Governance, Controls and Procedures
      • Reporting Frameworks and Indicators
      • Social incl. Communities
  • |
  • Careers
    • Careers
    • Explore our career opportunities
    • A range of possibilities
      • A range of possibilities
      • Market access
      • Marketing
      • Medical
      • Production
      • Research & Development
      • Consumer Healthcare
      • Vaccines careers
      • Student / Graduate / Young Professionals
      • Discover more possibilities
    • Grow with us
      • Grow with us
      • Diversity & Inclusion
      • Development opportunity: how Sanofi empowers you
      • Benefits
  • Investors
    • Investors
    • Company overview
      • Company overview
      • Sanofi at a glance
      • Strategy
      • Financial reporting center & Key data
      • Fixed income
    • Financial results and events
      • Financial results and events
      • Financial calendar
      • Quarterly earnings at a glance
      • Investor presentations
      • Annual General Meetings
      • Broker conferences
    • Sanofi share and ADRs
      • Sanofi share and ADRs
      • Share overview
        • Share overview
        • Shares & voting rights
        • Share repurchases
      • Sanofi stock chart
      • Shareholding calculator
      • Dividends
      • ADRs
      • Shareholding structure
      • Vara consensus
    • Corporate governance
      • Corporate governance
      • Governance
      • Board of Directors
      • Executive Committee
      • Specialist committees
      • Compensations
      • Standards & rules
      • Regulated agreements
      • Internal Control
    • Individual Shareholders
      • Individual Shareholders
      • Welcome to Sanofi
      • Being a shareholder
        • Being a shareholder
        • Five reasons to be a Sanofi shareholder
        • How to buy Sanofi shares
        • Registered shares
      • Shareholder events
        • Shareholder events
        • Financial Calendar
        • Annual General Meetings
        • Participate in General Meetings
      • Reports and publications
        • Reports and publications
        • Financial and CSR reports
        • Shareholder publications
      • Shareholders committee
    • Reports and publications
      • Reports and publications
      • Financial and CSR reports
      • Shareholder publications
    • Regulated information
    • Contacts
  • Media
    • Media
    • Press releases
      • Press releases
      • 2022
        • 2022
        • Press Release: Sanofi and Innovent Biologics enter strategic collaboration to accelerate development of oncology medicines and expand presence in China
      • 2021
      • 2020
      • 2019
      • 2018
    • Articles
      • Articles
      • 2019
    • Contacts
    • Media Alert
Worldwide
EN
  • EN
  • FR

MEDIA

Articles 2019

  • Home
  • Media
  • Articles
  • 2019
  • Sep 17, 2019 • ARTICLE
    Sanofi and Happify Health solidify collaboration around prescription DTx designed to address mental health in people with MS
  • May 19, 2019 • ARTICLE
    Forging new paths in R&D for cancer treatments
  • Apr 26, 2019 • ARTICLE
    Q1 Results in Brief
  • Apr 17, 2019 • ARTICLE
    Science is Our Passion: Learn What Inspires Sanofi Neuroscientist Lamya Shihabuddin
  • Feb 12, 2019 • ARTICLE
    Striving to Protect Human Health: The Quest for a Universal Flu Vaccine
  • Feb 7, 2019 • ARTICLE
    In Brief: Q4 and Full-Year Earnings
Sanofi

    Follow us

  • Contact
  • Legal notice
  • Privacy & Data Protection
  • Cookies policy
  • Corporate code of ethics
  • Our publications
  • Sitemap
  • Our websites
  • Accessibility: partial compliance

© Sanofi 2004-2022 - All rights reserved

You are about to leave sanofi.com

If you wish to continue to this external website, click Proceed.

It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.

PROCEED